Peter Vollenweider Selected Research

Sleep Apnea Syndromes (Sleep Apnea)

10/2019	Social inequalities in sleep-disordered breathing: Evidence from the CoLaus\|HypnoLaus study.
1/2018	Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive impairment?
1/2017	Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Vollenweider Research Topics

Disease

36	Hypertension (High Blood Pressure) 06/2024 - 04/2004
20	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2004
19	Insulin Resistance 07/2019 - 04/2002
17	Obesity 06/2024 - 03/2008
15	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2009
13	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017 - 12/2008
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 06/2003
8	Inflammation (Inflammations) 01/2021 - 01/2011
7	Dyslipidemias (Dyslipidemia) 01/2023 - 03/2008
6	Anxiety Disorders (Anxiety Disorder) 02/2024 - 01/2013
6	Coronary Disease (Coronary Heart Disease) 01/2016 - 02/2008
5	Obstructive Sleep Apnea 06/2023 - 01/2018
5	Apnea 12/2022 - 01/2017
5	Mental Disorders (Mental Disorder) 01/2020 - 03/2009
5	Gout 10/2019 - 06/2009
5	Overweight 09/2017 - 01/2011
5	Albuminuria 03/2016 - 09/2011
5	Necrosis 02/2015 - 01/2011
4	Chronic Renal Insufficiency 06/2024 - 01/2012
4	COVID-19 11/2022 - 01/2021
4	Weight Gain 01/2020 - 10/2013
4	Atherosclerosis 01/2011 - 04/2009
3	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 10/2013
3	Glucose Intolerance 01/2021 - 04/2002
3	Substance-Related Disorders (Drug Abuse) 01/2021 - 11/2014
3	Sleep Apnea Syndromes (Sleep Apnea) 10/2019 - 01/2017
3	Abdominal Obesity 01/2016 - 01/2012
3	Liver Diseases (Liver Disease) 09/2015 - 10/2008
2	Infections 12/2023 - 01/2023
2	Neoplasms (Cancer) 01/2021 - 10/2012
2	Atrophy 01/2020 - 01/2020
2	Hyponatremia 01/2020 - 11/2010
2	Diabetes Mellitus 01/2019 - 04/2014
2	Fatigue 01/2019 - 08/2012
2	Agoraphobia 01/2018 - 01/2015
2	Cognitive Dysfunction 01/2018 - 01/2017
2	Acute Coronary Syndrome 12/2017 - 08/2015
2	Myocardial Infarction 12/2017 - 01/2016
2	Alopecia (Baldness) 01/2017 - 11/2008
2	Hemochromatosis (Bronze Diabetes) 03/2015 - 10/2014
1	Genetic Risk Score 04/2024
1	Asthma (Bronchial Asthma) 02/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2024
1	Venous Thromboembolism 12/2023
1	Hemorrhage 12/2023

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2003
15	C-Reactive ProteinIBA 11/2022 - 07/2009
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
12	Insulin (Novolin)FDA Link 01/2021 - 04/2002
12	Uric Acid (Urate)IBA 10/2019 - 06/2003
12	HDL CholesterolIBA 10/2017 - 03/2008
11	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2011
10	Triglycerides (Triacylglycerol)IBA 01/2016 - 06/2003
9	LipidsIBA 11/2023 - 12/2008
9	AdiponectinIBA 01/2020 - 12/2009
8	CytokinesIBA 01/2021 - 11/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 04/2009
7	LDL CholesterolIBA 11/2013 - 02/2008
6	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2012
6	CholesterolIBA 01/2016 - 06/2003
5	UromodulinIBA 12/2021 - 10/2010
5	ElectrolytesIBA 11/2020 - 11/2010
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2012
5	InterleukinsIBA 01/2020 - 01/2011
5	HomocysteineIBA 01/2014 - 09/2011
4	IronIBA 12/2022 - 10/2014
4	Immunoglobulin G (IgG)IBA 11/2022 - 09/2016
4	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 01/2017
4	Oxygen (Dioxygen)IBA 01/2020 - 01/2017
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020 - 09/2016
4	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020 - 10/2013
4	LeptinIBA 05/2016 - 06/2003
4	EnzymesIBA 10/2015 - 10/2008
3	3,4-methylenedioxyethamphetamine (MDEA)IBA 02/2024 - 01/2018
3	AutoantibodiesIBA 01/2020 - 01/2017
3	HDL LipoproteinsIBA 10/2017 - 05/2012
3	AlbuminsIBA 03/2016 - 09/2011
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2015 - 02/2008
3	CreatinineIBA 01/2014 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 06/2013 - 12/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2004 - 06/2003
2	Hormones (Hormone)IBA 01/2021 - 01/2012
2	SodiumIBA 01/2020 - 10/2010
2	insulin receptor-related receptor (IRR)IBA 01/2019 - 09/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 01/2016
2	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 03/2016
2	Estrogens (Estrogen)FDA Link 01/2018 - 07/2017
2	Glycoproteins (Glycoprotein)IBA 10/2017 - 10/2011
2	Fibrinogen (Factor I)FDA Link 02/2015 - 06/2003
2	Genetic Markers (Genetic Marker)IBA 08/2013 - 03/2009
2	Interleukin-1beta (Interleukin 1 beta)IBA 02/2013 - 01/2012
2	AdipokinesIBA 07/2012 - 01/2012
2	Carrier Proteins (Binding Protein)IBA 12/2011 - 08/2011
1	BenzodiazepinesIBA 06/2024
1	BP 16IBA 04/2024
1	ORALIT (ORS)IBA 02/2024

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2012
3	Length of Stay 12/2023 - 01/2020
2	Polypharmacy 01/2021 - 09/2017
2	Percutaneous Coronary Intervention 12/2017 - 01/2016